Clinical Trial Update: Add-on Intravenous Immunoglobulins in Early Myositis [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/Phase 3 add-on intravenous immunoglobulin study for early inflammatory myopathies (myositis) is active but not currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Antisynthetase Syndrome
• Dermatomyositis
• Idiopathic Inflammatory Myopathy
• Immune-mediated Necrotizing Myopathy
• Myositis
• Polymyositis

Drugs mentioned

• Intravenous immunoglobulin (IVIG) (intravenous immunoglobulin)

Snippet

Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | Conditions: Inflammatory Myopathy, Idiopathic, Dermatomyositis | Phase 2, Phase 3 | Status: ACTIVE_NOT_RECRUITING